Clinical Trials
12 trialsNCT03269994 2025-10-21
Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?
Memorial Sloan Kettering Cancer Center
Phase 3 Completed
NCT05429203 2025-09-15
Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope
Stanford University
Phase NA Completed
NCT01555489 2025-05-04
Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca
Thomas Jefferson University
Phase 2 Terminated
NCT03535727 2024-12-31
A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1/2 Completed
NCT03077685 2024-06-24
Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma
NanOlogy, LLC
Phase 2 Completed
NCT02993731 2023-11-15
CanStem111P
Sumitomo Pharma America, Inc.
Phase 3 Completed
NCT01964430 2023-06-28
apact
Celgene
Phase 3 Completed
NCT03410914 2021-11-03
PATCH-DP
Sunnybrook Health Sciences Centre
Phase 2 Completed
NCT03188991 2021-06-14
Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms
NanOlogy, LLC
Phase 2 Completed
NCT01431794 2020-01-22
Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1/2 Terminated
NCT01088815 2019-04-26
Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00526331 2012-01-16
Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy
M.D. Anderson Cancer Center
Phase 4 Completed